Modern HIV medicine is based on a common genetic mutation. Now, researchers have traced where and when the mutation arose -- and how it protected our ancestors from ancient diseases.

Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.

Updated recommendations for antiretroviral nonoccupational postexposure prophylaxis (nPEP) for HIV have been published in the ...

I am writing to draw attention to a pressing issue that continues to affect HIV-positive individuals. The inadequacy of ...

A panelist discusses how the new doravirine and islatravir combination offers an alternative to integrase inhibitor-based ...

A panelist discusses how a new drug combination of doravirine and islatravir was compared to a standard bictegravir-based ...

In the hunt for a remedy, when the baton is passed from dedicated academic scientists to an innovative company to trusted community advocates, outcomes for society can be especially powerful.

The drugs, called NRTIs, have the potential to prevent a million cases of Alzheimer's every year, the researchers believe.

UVA scientists are calling for clinical trials to see if common HIV drugs could prevent up to 1 million new Alzheimer’s cases ...

A disruption in federal funds has jeopardized HIV testing and outreach in the U.S. South, and researchers warn of a ...

A disruption in federal funds has jeopardized HIV testing and outreach in Mississippi, and researchers warn of a resurgence of the epidemic.

Working closely with Elton John and David Furnish, Anne Aslett is one of the leading lights in the global response to the HIV ...